Hormone blockers used in combination with radiation therapy improves the survival of men with prostate cancer, The New York Times reported. More than 30% of men who undergo surgery have a recurrence of the disease. The results of a new study showed that 76.3% of men who received radiation and hormonal treatment were still alive after 12 years compared with 71.3% who received radiation alone. Additionally, men who received both treatments were less likely to die from prostate cancer (58% versus 13.4%, respectively) after 12 years, or have the cancer metastasize (14.5% versus 23%). The study authors are hopeful their findings will improve prostate cancer treatment in the future.
Two physicians allegedly overprescribed fentanyl to obtain $40 million in illicit profit, according to The Wall Street Journal. The abuse of fentanyl, which is more potent than heroin, has contributed to the growing opioid epidemic. A criminal trial of Dr John Couch and Dr Xiulu Ruan revealed deep ties between the physicians and fentanyl-maker Insys Therapeutics Inc, the Journal reported. The 2 physicians made millions by overprescribing the pain medication and dispensing fentanyl to patients from their pharmacy, which they co-owned and operated from the back of one of their pain clinics, according to the Journal.